* "Other pharmaceutical" primarily reflects sales of other human health pharmaceutical products, including products within the franchises not listed separately.
Citation formats
Pharmaceutical revenue of Merck & Co by therapy class 2025
Merck and Co. generates the majority of its worldwide revenue from its pharmaceutical operating segment. Sales from the company’s oncology business, which focuses on drugs that treat cancer, accounted for the ******* single share of its pharmaceutical revenue in 2025.
Revenues boosted by sales of cancer treatments
Merck & Co. is a global healthcare company that generated over ** billion U.S. dollars in total revenue in 2025. The company has two reportable operating segments: pharmaceutical and animal health. The pharmaceutical segment is split into nine franchises - or therapeutic areas; oncology generated some **** billion U.S. dollars in 2024, a significant increase compared to the previous year. Sales of cancer drug Keytruda were particularly strong and increased from *** billion in 2018 to nearly ** billion U.S. dollars in 2024.
An overview of Merck’s global operations
The corporate headquarters of Merck & Co. is located in New Jersey, and the company’s domestic market is the region that continues to generate the most of its revenue. Outside the United States, Merck & Co. has operations in Europe, the Middle East, Africa, Asia Pacific, and Latin America. The company’s sales in China fluctuated between 2021 and 2024. Operating business strategies in emerging markets, such as China, can come with challenges, but they offer huge potential for growth over time.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Merck & Co., & U.S. Securities and Exchange Commission. (February 24, 2026). Pharmaceutical revenue of Merck & Co. in 2025, by therapy area (in million U.S. dollars) [Graph]. In Statista. Retrieved May 09, 2026, from https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co., und U.S. Securities and Exchange Commission. "Pharmaceutical revenue of Merck & Co. in 2025, by therapy area (in million U.S. dollars)." Chart. February 24, 2026. Statista. Accessed May 09, 2026. https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co., U.S. Securities and Exchange Commission. (2026). Pharmaceutical revenue of Merck & Co. in 2025, by therapy area (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 09, 2026. https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co., and U.S. Securities and Exchange Commission. "Pharmaceutical Revenue of Merck & Co. in 2025, by Therapy Area (in Million U.S. Dollars)." Statista, Statista Inc., 24 Feb 2026, https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
Merck & Co. & U.S. Securities and Exchange Commission, Pharmaceutical revenue of Merck & Co. in 2025, by therapy area (in million U.S. dollars) Statista, https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/ (last visited May 09, 2026)
Pharmaceutical revenue of Merck & Co. in 2025, by therapy area (in million U.S. dollars) [Graph], Merck & Co., & U.S. Securities and Exchange Commission, February 24, 2026. [Online]. Available: https://www.statista.com/statistics/270839/revenue-of-merck-by-segment/
